A study on the safety, tolerability and immune response of meningococcal combined ABCWY vaccine in healthy infants

Trial Identifier: 217043
Sponsor: GlaxoSmithKline
Start Date: November 2021
Primary Completion Date: March 2025
Study Completion Date: March 2025

Trial Locations

Country Location
DOMINICAN_REPUBLIC Santo Domingo Este, DOMINICAN_REPUBLIC, N/A
FINLAND Espoo, FINLAND, 02230
FINLAND Helsinki, FINLAND, 00100
FINLAND Jarvenpaa, FINLAND, 04400
FINLAND Kokkola, FINLAND, 67100
FINLAND Oulu, FINLAND, 90220
FINLAND Seinajoki, FINLAND, 60100
GERMANY Gilching, GERMANY, 82205
GERMANY Schoenau am Koenigssee, GERMANY, 83471
HONDURAS San Pedro Sula, HONDURAS, 21101
POLAND Bydgoszcz, POLAND, 85-048
POLAND Krakow, POLAND, 30-644
POLAND Krakow, POLAND, 30-348
POLAND Lubon, POLAND, 62-030
POLAND Siemianowice Slaskie, POLAND, 41-103
POLAND Torun, POLAND, 87-100
POLAND Trzebnica, POLAND, 55-100
POLAND Warszawa, POLAND, 02-647
POLAND Wroclaw, POLAND, 50368
SOUTH_AFRICA Parow Valley, SOUTH_AFRICA, 7505
SOUTH_AFRICA Soweto Gauteng, SOUTH_AFRICA, 2013
SPAIN ALMERIA, SPAIN, 04120
SPAIN Burgos, SPAIN, 09006
SPAIN Madrid, SPAIN, 28041
SPAIN Madrid, SPAIN, 28040
SPAIN Madrid, SPAIN, 28046
SPAIN MADRID, SPAIN, 28222
SPAIN MALAGA, SPAIN, 29004
SPAIN Marbella, SPAIN, 29600
SPAIN Santiago de Compostela, SPAIN, 15706
UNITED_KINGDOM Exeter, UNITED_KINGDOM, EX2 5DW
UNITED_KINGDOM Oxford, UNITED_KINGDOM, OX3 7LE